Inventor
ANDREW MADIN
Inventor
GB
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes21%
C07CAcyclic or carbocyclic compounds4%
Y02ATechnologies for adaptation to climate change4%
PatentTitleYear
12,378,249Isoquinoline compounds and uses thereof202512,297,210Naphthyridine compounds and uses thereof202512,208,088Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof202511,993,595Compounds202411,958,833Compounds202411,944,606Azaindoles as inhibitors of HPK1202411,566,003Isoquinolines as inhibitors of HPK1202311,472,798Compounds202211,414,402Sulfonamide-substituted cyanopyrrolidines with activity as DUB inhibitors202211,370,784Cyano-substituted heterocycles with activity as inhibitors of USP302022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2024Patents assigned to MISSION THERAPEUTICS LTD (5)· patent assignee history
2022–2025Based in GB· patent location history
2023–2025Patents assigned to GENENTECH INC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 5 | 2023–2025 |
| MISSION THERAPEUTICS LTD | 5 | 2022–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 10 | 2022–2025 |